NCT06132568 - VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 9, 2024

Primary Completion Date

October 24, 2024

Study Completion Date

January 17, 2025

Conditions

High-risk Percutaneous Coronary InterventionHeart Disease, Coronary

Interventions

DEVICE

VITALYST System

The VITALYST System is a temporary ventricular support device indicated for use during high-risk percutaneous coronary interventions (HR-PCI) performed electively in hemodynamically stable subjects with severe coronary artery disease.

Trial Locations (5)

10032

Columbia University Medical Center/New York Presbyterian Hospital, New York

30309

Piedmont Heart Institute, Atlanta

02115

Brigham and Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

222 42

Skane University Hospital, Lund